Actively Recruiting
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
Led by Se-Hoon Lee · Updated on 2024-12-03
800
Participants Needed
3
Research Sites
403 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is designed to identify the predictive biomarker for immunotherapy using patient samples (tumor tissue, blood, fecal material) who treated with immune checkpoint inhibitor.
CONDITIONS
Official Title
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Histologically confirmed lung cancer diagnosis
- Patient treated with immune checkpoint inhibitor
You will not qualify if you...
- None specified
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Samsung Medical Center
Seoul, Gangnam-gu, South Korea
Actively Recruiting
2
Seoul National University Hospital
Seoul, Joungro-gu, South Korea
Actively Recruiting
3
Asan Medical Center
Seoul, Songpa-gu, South Korea
Not Yet Recruiting
Research Team
S
Se-hoon Lee, MD
CONTACT
J
Jinhee Seo
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here